Biovian is a Finnish CDMO dedicated to transform scientific innovations into life-saving therapeutics by providing premium services to biotech companies developing innovative gene therapies and biopharmaceuticals. With 20 years of operational experience, strong scientific expertise, a deep understanding of regulatory requirements, and a commitment to quality and GMP compliance, Biovian empowers clients to bring new therapies to patients worldwide.

Biovian’s One-Stop-Shop CDMO services include the production of:
Viral vectors (AAV, adenovirus, etc.)
Microbial recombinant proteins
Plasmid DNA
Aseptic Fill and Finish
Quality Control Services

Biovian thrives on building long-term partnerships and delivering cost-effective solutions. The expert teams with profound knowledge in Process Development, Technical Transfer, GMP manufacturing, and Analytical Development are committed to taking your project from laboratory bench to the clinic.